New hope for patients who have run out of options for blood cancers

NCT ID NCT05458297

Summary

This study is testing a new drug called zilovertamab vedotin (MK-2140) for people with several types of advanced B-cell blood cancers that have come back or stopped responding to other treatments. The main goals are to see if the drug is safe and if it can shrink or eliminate the cancer. It is for adults with specific types of lymphoma or leukemia who have already tried at least one or two other standard treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 5002)

    Uppsala, Uppsala County, 751 85, Sweden

  • Alaska Oncology and Hematology ( Site 0037)

    Anchorage, Alaska, 99508, United States

  • Allan Blair Cancer Centre-Care Services ( Site 0208)

    Regina, Saskatchewan, S4T 7T1, Canada

  • Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 6001)

    Ankara, 06100, Turkey (Türkiye)

  • Avera Cancer Institute- Research ( Site 0011)

    Sioux Falls, South Dakota, 57105, United States

  • Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare -Azienda Ospedaliera Nazionale SS. Ant ( Site 0803)

    Alessandria, 15121, Italy

  • BC Cancer Vancouver-Clinical Trials Unit ( Site 0201)

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Banner MD Anderson Cancer Center ( Site 0040)

    Gilbert, Arizona, 85234, United States

  • Banner MD Anderson Cancer Center - University Medical Center Phoenix-Medical Oncology ( Site 0036)

    Phoenix, Arizona, 85006, United States

  • Beijing Cancer hospital ( Site 1200)

    Beijing, Beijing Municipality, 100142, China

  • Cancer Care Specialists of Illinois ( Site 0031)

    Decatur, Illinois, 62526, United States

  • Cancer Institute Hospital of JFCR ( Site 1101)

    Koto, Tokyo, 135-8550, Japan

  • Carmel Hospital ( Site 0709)

    Haifa, 3436212, Israel

  • Centro Medico Monte Carmelo ( Site 1702)

    Arequipa, Ariqipa, 04001, Peru

  • Centro de Estudios Clínicos SAGA-CECSAGA ( Site 1907)

    Santiago, Region M. de Santiago, 7500653, Chile

  • Centrum Onkologii Ziemi Lubelskiej-Oddzial Hematologiczny ( Site 1006)

    Lublin, Lublin Voivodeship, 20-090, Poland

  • Champalimaud Foundation ( Site 2002)

    Lisbon, Lisbon District, 1400-038, Portugal

  • Clinica Universidad de Navarra ( Site 4005)

    Pamplona, Navarre, 31008, Spain

  • Clínica Alemana de Santiago ( Site 1903)

    Santiago, Region M. de Santiago, 7650568, Chile

  • Clínica Inmunocel ( Site 1910)

    Santiago, Region M. de Santiago, 7580206, Chile

  • Dana-Farber Cancer Institute-Lymphoma ( Site 0026)

    Boston, Massachusetts, 02215, United States

  • Ege Universitesi Hastanesi ( Site 6002)

    Bornova, İzmir, 35100, Turkey (Türkiye)

  • Emek Medical Center-Hematology Unit ( Site 0705)

    Afula, 1834111, Israel

  • Fakultni nemocnice Ostrava-Klinika Hematoonkologie ( Site 0301)

    Ostrava, Moravskoslezský kraj, 708 52, Czechia

  • Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0300)

    Brno, Brno-mesto, 625 00, Czechia

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -ISTITUTO DI EMATOLOGIA ( Site 0804)

    Roma, 00168, Italy

  • Fudan University Shanghai Cancer Center ( Site 1208)

    Shanghai, Shanghai Municipality, 200032, China

  • Galilee Medical Center ( Site 0710)

    Nahariya, 2210001, Israel

  • Greenebaum Comprehensive Cancer Center-Hematology & Multiple Myeloma ( Site 0010)

    Baltimore, Maryland, 21201, United States

  • Hadassah Medical Center ( Site 0701)

    Jerusalem, 9112001, Israel

  • Henan Cancer Hospital-hematology department ( Site 1212)

    Zhengzhou, Henan, 450003, China

  • Henry Ford Hospital ( Site 0035)

    Detroit, Michigan, 48202, United States

  • Hokkaido University Hospital ( Site 1104)

    Sapporo, Hokkaido, 060-8648, Japan

  • Hospital Paulistano-Americas Oncologia ( Site 1805)

    São Paulo, 01321-001, Brazil

  • Hospital Universitari Vall d'Hebron ( Site 4004)

    Barcelona, Catalonia, 08035, Spain

  • Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca-Hematology ( Site 4001)

    Salamanca, 37007, Spain

  • Humanitas-U.O di Oncologia medica ed Ematologia ( Site 0802)

    Rozzano, Milano, 20089, Italy

  • IC La Serena Research ( Site 1909)

    La Serena, Coquimbo Region, 1720430, Chile

  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 1808)

    São Paulo, 01246-000, Brazil

  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 1700)

    Lima, 15038, Peru

  • IRCCS - AOU di Bologna-SSD: Diagnosi e terapie dei linfomi e delle sindromi linfoproliferative cron ( Site 0800)

    Bologna, Emilia-Romagna, 40138, Italy

  • Icahn School of Medicine at Mount Sinai ( Site 0023)

    New York, New York, 10029, United States

  • Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 4003)

    L'Hospitalet Del Llobregat, Barcelona, 08908, Spain

  • Instituto Nacional de Câncer - INCA-Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico HC1 ( Site 1809)

    Rio de Janeiro, 20231-050, Brazil

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2000)

    Porto, 4200-072, Portugal

  • Jewish General Hospital ( Site 0202)

    Montreal, Quebec, H3T 1E2, Canada

  • Jiangxi Provincial Cancer Hospital ( Site 1213)

    Nanchang, Jiangxi, 330029, China

  • Jilin Province Tumor Hospital-oncology department ( Site 1220)

    Chuangchun, Jilin, 130012, China

  • Kindai University Hospital ( Site 1102)

    Sakai, Osaka, 590-0197, Japan

  • Kyushu University Hospital ( Site 1105)

    Fukuoka, 812-8582, Japan

  • Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 1807)

    Natal, Rio Grande do Norte, 59075-740, Brazil

  • London Health Sciences Centre ( Site 0203)

    London, Ontario, N6A 5W9, Canada

  • MD Anderson Cancer Center ( Site 4006)

    Madrid, Madrid, Comunidad de, 28033, Spain

  • Massachusetts General Hospital ( Site 0018)

    Boston, Massachusetts, 02114, United States

  • Medical College of Wisconsin ( Site 0021)

    Milwaukee, Wisconsin, 53226, United States

  • Medical Oncology Associates, PS ( Site 0005)

    Spokane, Washington, 99208, United States

  • Mega Medipol-Hematology ( Site 6009)

    Stanbul, Istanbul, 34214, Turkey (Türkiye)

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 1002)

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • National Cancer Center Hospital ( Site 1103)

    Chuo-ku, Tokyo, 104-0045, Japan

  • National Cancer Centre Singapore ( Site 1500)

    Singapore, Central Singapore, 168583, Singapore

  • National Hospital Organization Nagoya Medical Center ( Site 1108)

    Nagoya, Aichi-ken, 460-0001, Japan

  • North Estonia Medical Centre Foundation ( Site 0401)

    Tallinn, Harju, 13419, Estonia

  • Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0007)

    Saint Matthews, Kentucky, 40207, United States

  • Okayama University Hospital ( Site 1107)

    Okayama, 700-8558, Japan

  • Ondokuz Mayıs Universitesi-Oncology department ( Site 6004)

    Samsun, 55139, Turkey (Türkiye)

  • Pratia MCM Krakow ( Site 1001)

    Krakow, Lesser Poland Voivodeship, 30-727, Poland

  • Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0200)

    Toronto, Ontario, M5G 2M9, Canada

  • QEII Health Sciences Centre - Victoria General Site ( Site 0213)

    Halifax, Nova Scotia, B3H 2Y9, Canada

  • Rambam Health Care Campus-Hematology and Bone Marrow Transplantation ( Site 0706)

    Haifa, 3109601, Israel

  • Sahlgrenska Universitetssjukhuset ( Site 5003)

    Gothenburg, Västra Götaland County, 413 45, Sweden

  • Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA w Olsztynie-Oddzial Kliniczny Hematologii ( Site 1007)

    Olsztyn, Warmian-Masurian Voivodeship, 10-228, Poland

  • Samsung Medical Center ( Site 1301)

    Seoul, 06351, South Korea

  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0014)

    Fargo, North Dakota, 58122, United States

  • Seoul National University Hospital ( Site 1300)

    Seoul, 03080, South Korea

  • Sheba Medical Center-Hemato Oncology ( Site 0700)

    Ramat Gan, 5265601, Israel

  • Skånes Universitetssjukhus Lund ( Site 5000)

    Lund, Skåne County, 22185, Sweden

  • Soroka Medical Center-Hematology Department ( Site 0707)

    Beersheba, 8410101, Israel

  • Southern Medical University Nanfang Hospital ( Site 1202)

    Guangzhou, Guangdong, 510515, China

  • St. James's Hospital ( Site 0600)

    Dublin, D08 E9P6, Ireland

  • Sun Yat-sen University Cancer Center ( Site 1201)

    Guangzhou, Guangdong, 510700, China

  • Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Hematologii i Transplantacji S ( Site 1010)

    Kielce, Świętokrzyskie Voivodeship, 25-734, Poland

  • The Affiliated Hospital of Xuzhou Medical College ( Site 1223)

    Xuzhou, Jiangsu, 221000, China

  • The Christie NHS Foundation Trust ( Site 7007)

    Manchester, m20 4bx, United Kingdom

  • The Churchill Hospital ( Site 7002)

    Oxford, Oxfordshire, OX3 7LE, United Kingdom

  • The First Affiliated Hospital of Nanchang University ( Site 1204)

    Nanchang, Jiangxi, 330006, China

  • The First Affiliated Hospital of Soochow University-hematology department ( Site 1218)

    Suzhou, Jiangsu, 215006, China

  • The First Affiliated Hospital, Zhejiang University ( Site 1211)

    Hangzhou, Zhejiang, 310003, China

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004)

    Columbus, Ohio, 43210, United States

  • The Moncton Hospital-Oncology ( Site 0211)

    Moncton, New Brunswick, E1C 6Z8, Canada

  • The Royal Cornwall Hospital-Haematology ( Site 7006)

    Truro, Cornwall, TR1 3LJ, United Kingdom

  • Tohoku University Hospital ( Site 1106)

    Sendai, Miyagi, 980-8574, Japan

  • Tokai University Hospital ( Site 1100)

    Isehara, Kanagawa, 259-1193, Japan

  • Tongji Hospital Tongji Medical,Science & Technology ( Site 1221)

    Wuhan, Hubei, 430030, China

  • Trakya University ( Site 6005)

    Edirne, 22030, Turkey (Türkiye)

  • Tufts Medical Center ( Site 0024)

    Boston, Massachusetts, 02111, United States

  • Unidade Local de Saude de Braga - Hospital de Braga ( Site 2001)

    Braga, 4710-243, Portugal

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1210)

    Wuhan, Hubei, 430023, China

  • Universitaetsklinikum Koeln ( Site 0506)

    Cologne, North Rhine-Westphalia, 50937, Germany

  • Universitaetsklinikum Ulm. ( Site 0502)

    Ulm, Baden-Wurttemberg, 89081, Germany

  • University College London Hospital ( Site 7001)

    London, London, City of, NW1 2PG, United Kingdom

  • University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008)

    Aurora, Colorado, 80045, United States

  • University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038)

    Fairway, Kansas, 66205, United States

  • University of Michigan ( Site 0009)

    Ann Arbor, Michigan, 48109, United States

  • University of Wisconsin Hospitals and Clinics-Carbone Cancer Center ( Site 0030)

    Madison, Wisconsin, 53792, United States

  • Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0302)

    Prague, 128 08, Czechia

  • West China Hospital of Sichuan University-Head and Neck Oncology ( Site 1206)

    Chengdu, Sichuan, 610041, China

  • Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumat-Oddiał Hematologii Ogólnej ( Site 1008)

    Lodz, Łódź Voivodeship, 93-513, Poland

  • Zhejiang Cancer Hospital ( Site 1214)

    Hangzhou, Zhejiang, 310005, China

  • Zhujiang Hospital ( Site 1207)

    Guangzhou, Guangdong, 510280, China

Conditions

Explore the condition pages connected to this study.